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Figure 1 (A) The course of disease is shown as a timeline. Recurrences are indicated by the 
respective year and treatments in green. (B) Ulcer with raised borders of the perianal skin. (C) 
Histology shows a well- differentiated squamous cell carcinoma.
We report the case of a 60- year- old patient 
with a recurrent squamous cell carcinoma 
(SCC) of the perianal skin. In 2012, an ulcer-
ated perianal lesion was excised. The initial 
clinical diagnosis was an anal fissure, but 
histology showed a well- differentiated invasive 
SCC. Staging by pelvic MRI and proctoscopy 
did not show any pathology. HPV (human 
papillomavirus), PCR and STI (sexually trans-
mitted infections) screening were negative. 
None of the known risk factors for perianal 
SCC applied: immunosuppression, high- risk 
types of HPV (16 and 18), men who have sex 
with men or smoking. The patient reported 
of chronic anal itch and scratching for many 
years. No evidence of lichen sclerosus were 
found clinically or histologically.
The patient was followed up by quarterly 
clinical examinations, regular proctoscopies 
and pelvic MRI scans. In 2014, 2 years after 
the initial diagnosis, two local recurrences 
appeared in short succession (figure 1). Our 
multidisciplinary tumour board suggested 
either chemoradiation or local resection. 
After shared decision making with the 
patient, we opted for local resection, adju-
vant therapy with topical imiquimod 5% and 
regular follow- ups. The patient had no signs 
of disease for 3 years. After 2017, he had three 
relapses, each approximately 1 year apart. We 
treated with local resection and imiquimod. 
After the last relapse, we initiated systemic 
acitretin (Neotigason), a second generation 
retinoid, which is often used as chemopro-
phylaxis for non- melanoma skin cancer.1 2 
At the moment, the patient has been disease 
free for 4 months.
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SCC of the perianal skin are rare tumours. They 
belong to the entity of anal cancers, together with SCC 
of the anal canal. According to the European Society 
for Medical Oncology (ESMO) guidelines, perianal SCC 
may be treated by local resection, provided they are small 
(<2 cm) and well differentiated.1 In contrast, standard of 
care for anal canal SCC is chemoradiation.
Chung et al have reported that 60% of anal SCC carry 
alterations in the phosphoinositol-3- kinase pathway 
(PI3K/AKT/mTOR). HPV- negative anal SCC were 
commonly mutated in TP53 and CDKN2A.2 A Foundatio-
nOne analysis of our patient’s tumour revealed genetic 
alterations in TP53 and CDKN2A/B, but not in the PI3K 
pathway, in line with the mutations observed in HPV- 
negative anal SCC. The tumour mutational burden was 
1 Mut/Mb, thus much lower than in cutaneous SCC 
(cSCC).3 This might be the result of minimal UV expo-
sure of the perianal skin and lack of HPV- mediated muta-
genesis in this case.
In conclusion, SCC of the perianal skin are rare and 
often misdiagnosed as anal fissure, eczema or haemor-
rhoids.4 Chronic itch and scratching might play a patho-
genic role due to mechanical stress and inflammation.5 
For most cases, surgery is first- line therapy, in contrast to 
the more aggressive approach in anal canal SCC. Peri-
anal SCC probably belongs to the spectrum of different 
biological subtypes of cSCC and might share patho-
genic mechanisms with cSCC of non- sun- exposed areas. 
Further research on genomic profiling of anal SCC may 
define molecular subtypes and ultimately guide treat-
ment decisions.
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